Prolonged Opioid-Sparing Pain Control after Hemorrhoidectomy with Liposome Bupivacaine: Results from a Cohort of 95 Patients

Journals Menu

Follow SCIRP

ISSN Print: 2329-3268
ISSN Online: 2329-3276
www.scirp.org/journal/pst
E-mail: pst@scirp.org

"Prolonged Opioid-Sparing Pain Control after Hemorrhoidectomy with Liposome Bupivacaine: Results from a Cohort of 95 Patients"
written by Allen B. Jetmore, Douglas Hagen,
published by Pain Studies and Treatment, Vol.4 No.1, 2016

has been cited by the following article(s):

[1]	Liposomal compared to 0.25% bupivacaine in patients undergoing hemorrhoidectomy: A pre-and post-implementation quality improvement evaluation
	Journal of Clinical …, 2022

[2]	Liposomal Bupivacaine Compared to Plain Local Anesthetics to Reduce Postsurgical Pain: An Updated Meta-Analysis of Randomized Controlled Trials
	Pain Research and Treatment, 2018

[3]	Liposome Bupivacaine Compared to Plain Local Anesthetics to Reduce Postsurgical Pain: An Updated Meta-Analysis of Randomized Controlled Trials
	Pain Research and Treatment, 2018

[1]	Liposomal compared to 0.25% bupivacaine in patients undergoing hemorrhoidectomy: A pre- and post-implementation quality improvement evaluation Journal of Clinical Anesthesia, 2022 DOI:10.1016/j.jclinane.2022.110868

[2]	Liposomal compared to 0.25% bupivacaine in patients undergoing hemorrhoidectomy: A pre- and post-implementation quality improvement evaluation Journal of Clinical Anesthesia, 2022 DOI:10.1016/j.jclinane.2022.110868

[3]	Liposome Bupivacaine Compared to Plain Local Anesthetics to Reduce Postsurgical Pain: An Updated Meta-Analysis of Randomized Controlled Trials Pain Research and Treatment, 2018 DOI:10.1155/2018/5710169

Follow SCIRP